keyword
https://read.qxmd.com/read/38181816/venous-thromboembolism-in-children-the-rivaroxaban-experience
#21
JOURNAL ARTICLE
Luca Spiezia, Elena Campello, Daniela Tormene, Paolo Simioni
The incidence of venous thromboembolism (VTE) in the pediatric population has increased more than 10-fold in the last 20 years, as a consequence of the advancement of resuscitation and surgical techniques and the global increase in life expectancy of children suffering from chronic pathologies. Monitoring anticoagulant therapy to achieve outcomes within the target range in childhood VTE, parenteral administration of medications, and frequent blood tests in children are often cumbersome. Availability of safe and effective oral agents with pediatric data to support use would be of clear benefit...
January 5, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38176861/risk-assessment-and-real-world-outcomes-in-chronic-thromboembolic-pulmonary-hypertension-insights-from-a-uk-pulmonary-hypertension-referral-service
#22
JOURNAL ARTICLE
David G Kiely, Neil Hamilton, Steven Wood, Charlotte Durrington, Fernando Exposto, Ruvimbo Muzwidzwa, Louise Raiteri, Amélie Beaudet, Audrey Muller, Rafael Sauter, Nadia Pillai, Allan Lawrie
OBJECTIVES: This study was conducted to evaluate the ability of risk assessment to predict healthcare resource utilisation (HCRU), costs, treatments, health-related quality of life (HRQoL) and survival in patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH). DESIGN: Retrospective observational study. SETTING: Pulmonary hypertension referral centre in the UK. PARTICIPANTS: Adults diagnosed with CTEPH between 1 January 2012 and 30 June 2019 were included...
January 4, 2024: BMJ Open
https://read.qxmd.com/read/38160810/cardiovascular-comorbidities-are-associated-with-dermatomyositis-a-cross-sectional-study-in-the-all-of-us-research-program
#23
JOURNAL ARTICLE
Jill T Shah, Keya T Shah, Daniel R Mazori, Avrom S Caplan, Emily Hejazi, Michael S Garshick, Alisa N Femia
This study does not address how DM treatments (e.g. systemic steroids, methotrexate) might influence CVD development in DM and further investigation is warranted. Additional limitations include using EHRs which may have diagnostic inaccuracies/omissions, lack of data on clinical features/severity/subtype, and use of a non-representative U.S. cohort. Our findings are important both for prognosis and clinical care, suggesting DM patients should be screened for CVD risk factors to potentially reduce the increased risk of cardiovascular events and CVD-related mortality in DM...
December 29, 2023: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38046038/kidney-function-estimators-for-drug-dose-adjustment-of-direct-oral-anticoagulants-in-older-adults-with-atrial-fibrillation
#24
JOURNAL ARTICLE
Cédric Villain, Natalie Ebert, Tim Bothe, Muhammad Barghouth, Anna Pöhlmann, Anne-Katrin Fietz, Antonios Douros, Nina Mielke, Elke Schaeffner
BACKGROUND: The Cockcroft-Gault equation (CrClC-G ) is recommended for dose adjustment of direct oral anticoagulant drugs (DOACs) to kidney function. We aimed to assess whether defining DOAC dose appropriateness according to various kidney function estimators changed the associations between dose appropriateness and adverse events in older adults with atrial fibrillation (AF). METHODS: Participants of the Berlin Initiative Study with AF and treated with DOACs were included...
December 2023: Clinical Kidney Journal
https://read.qxmd.com/read/38041115/an-observational-study-of-an-adjusted-patient-blood-management-protocol-intended-to-lower-rates-of-transfusion-following-total-knee-arthroplasty-in-patients-with-preoperative-anemia
#25
JOURNAL ARTICLE
Hervé Hourlier, Peter Fennema
BACKGROUND: Patients with preoperative anemia have a higher risk of requiring blood transfusion after major orthopedic surgery due to increased blood loss and closer transfusion thresholds. Various patient blood management (PBM) policies aim to reduce transfusion rates. This observational study aimed to investigate blood loss and evaluate the effectiveness of an adjusted surgical PBM protocol in patients with anemic chronic disease (ACD) undergoing elective total knee arthroplasty (TKA)...
December 2, 2023: Journal of Orthopaedic Surgery and Research
https://read.qxmd.com/read/38020573/venous-thromboembolism-associated-with-severe-dyspnoea-and-asthma-in-102%C3%A2-792-adults
#26
JOURNAL ARTICLE
Kristin Felicia Nilausen, Eskild Morten Landt, Suzan Al-Shuweli, Børge G Nordestgaard, Uffe Bødtger, Morten Dahl
BACKGROUND: The most recent guideline on acute pulmonary embolism (PE) indicates possible long-term sequelae such as dyspnoea and chronic thromboembolic pulmonary hypertension after a PE event. However, effects on lung function or asthma risk have not been evaluated in the general population. METHODS: We tested whether individuals with a venous thromboembolism (VTE) encompassing PE and deep vein thrombosis (DVT) have reduced lung function, or greater risks of dyspnoea and asthma using data from 102 792 adults from the Copenhagen General Population Study...
November 2023: ERJ Open Research
https://read.qxmd.com/read/37994384/balloon-pulmonary-angioplasty-for-chronic-thromboembolic-pulmonary-hypertension-due-to-septic-emboli
#27
Zachary L Steinberg, Samuel G Rayner, Peter J Leary
We present the case of a 28-year-old woman with a history of tricuspid valve endocarditis leading to chronic thromboembolic pulmonary hypertension (CTEPH) with multiple pulmonary artery chronic total occlusions (CTOs) due to septic emboli. Following a multidisciplinary care discussion, the patient was brought forward for balloon pulmonary angioplasty (BPA) with successful revascularization of all chronically occluded territories. This case highlights advances in pulmonary artery CTO interventions and demonstrates the feasibility of BPA for CTEPH patients with a history of septic emboli...
November 22, 2023: Catheterization and Cardiovascular Interventions
https://read.qxmd.com/read/37976732/comparing-u-s-and-canadian-treatment-patterns-on-venous-thromboembolism-outcomes-in-the-garfield-vte-registry
#28
JOURNAL ARTICLE
Adrian C Chen, Amit S Rao, Alisha Oropallo, Samuel Z Goldhaber, Meg E Fluharty, Uma Maheshwari, Marc Carrier, Alexander G G Turpie, Karen Pieper, Gloria Kayani, Ajay K Kakkar
BACKGROUND: Economically developed countries continue to find that venous thromboembolism (VTE) is a major cause of morbidity and mortality. OBJECTIVE: To compare baseline risk profiles and patient workflow patterns between the United States (U.S.) and Canadian management of VTE patients from 2014 to 2017. METHODS: The Global Anticoagulant Registry in the FIELD (GARFIELD-VTE) is a prospective, observational study of 10,679 patients with objectively confirmed VTE, followed for 3 years...
December 2023: Thrombosis Research
https://read.qxmd.com/read/37971889/association-of-egfr-and-albuminuria-with-venous-thromboembolism
#29
JOURNAL ARTICLE
Zhong Zheng, Krutika Pandit, Alex R Chang, Jung-Im Shin, David M Charytan, Morgan E Grams, Aditya Surapaneni
BACKGROUND: CKD has been implicated as a risk factor of venous thromboembolism, but the evidence is limited to relatively healthy populations. The objective of this study was to discern whether parameters of kidney function and damage are associated with the occurrence of venous thromboembolism after hospitalization. METHODS: We conducted a retrospective study including 23,899 and 11,552 adult individuals hospitalized within Geisinger Health System and New York University (NYU) Langone Health from 2004 to 2019 and 2012 to 2022, respectively...
March 1, 2024: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/37970576/pulmonary-endarterectomy-for-chronic-thromboembolic-pulmonary-hypertension-in-cape-town-south-africa
#30
JOURNAL ARTICLE
S A Davies-van Es, T C Pennel, J Brink, G J Symons, G L Calligaro
BACKGROUND: Pulmonary endarterectomy (PEA) is the only definitive and potentially curative therapy for chronic thromboembolic pulmonary hypertension (CTEPH), associated with impressive improvements in symptoms and haemodynamics. However, it is only offered at a few centres in South Africa. The characteristics and outcomes of patients undergoing PEA in Cape Town have not been reported previously. OBJECTIVES: To assess the difference in World Health Organization functional class (WHO-FC) before and at least 6 weeks after surgery...
2023: African journal of thoracic and critical care medicine
https://read.qxmd.com/read/37965400/incidence-of-thromboembolism-in-covid-19-patients-in-intensive-care-units-a-retrospective-cohort-analysis
#31
JOURNAL ARTICLE
Ayse Z Turan Civraz, Ipek Duzyol, Emine Atli, Cigdem Caglayan, Emine Ozer Yurt, Adnan Ata, Mehmet Yilmaz, Berna Karakoyun
INTRODUCTION: Coronavirus disease 2019 (COVID-19) infection was declared a pandemic, causing high mortality and morbidity worldwide. It predisposes patients to both arterial and venous thromboembolism, which causes high mortality, and is one of the most serious complications of the disease. OBJECTIVE: The aim of this retrospective study was to determine the frequency of thromboembolic events in patients diagnosed with COVID-19 in the intensive care unit (ICU) and to identify the factors causing thromboembolism...
October 2023: Curēus
https://read.qxmd.com/read/37956897/design-and-rationale-for-the-direct-oral-anti-coagulant-apixaban-in-left-ventricular-assist-devices-doac-lvad-study
#32
JOURNAL ARTICLE
Matthew Dimond, Mary Looby, Bhruga Shah, Shashank S Sinha, Iyad Isseh, Allman T Rollins, Ahmad A Abdul-Aziz, Jamie Kennedy, Daniel G Tang, Katherine M Klein, Samantha Casselman, Christen Vermeulen, Wendy Sheaffer, Meredith Snipes, Christopher M O'Connor, Palak Shah
Implantable left ventricular assist devices (LVAD) therapy is used to improve quality of life, alleviate symptoms, and extend survival in patients with advanced heart failure (HF). LVAD patients require chronic anticoagulation to reduce the risk of thromboembolic complications and frequently experience bleeding events. Apixaban is a direct oral anticoagulant which has become first-line therapy for patients with non-valvular atrial fibrillation and venous thromboembolism; however, its safety in LVAD patients has not been well-characterized...
November 11, 2023: Journal of Cardiac Failure
https://read.qxmd.com/read/37893576/associated-bacterial-coinfections-in-covid-19-positive-patients
#33
JOURNAL ARTICLE
Eugen Radu Boia, Alexandru Romulus Huț, Alexandra Roi, Ruxandra Elena Luca, Ioana Roxana Munteanu, Ciprian Ioan Roi, Mircea Riviș, Simina Boia, Adina Octavia Duse, Dan Dumitru Vulcănescu, Florin George Horhat
Background and Objectives : The aim of this study was to identify specific rhino- and oropharyngeal microbiological pathogens as well as associated comorbidities that favor SARS-CoV-2 infection and corelate them. Materials and Methods : This prospective clinical study enrolled 61 patients (28 COVID-19-positive and 33 controls) who were tested for other comorbidities and co-existence of associated oral pathogenic microbiota. Results : A total of 247 bacterial isolates were identified in the bacterial cultures in both groups...
October 19, 2023: Medicina
https://read.qxmd.com/read/37889200/prognostic-value-of-chronic-kidney-disease-in-patients-undergoing-left-atrial-appendage-occlusion
#34
JOURNAL ARTICLE
Domenico G Della Rocca, Michele Magnocavallo, Christoffel J Van Niekerk, Thomas Gilhofer, Grace Ha, Gabriele D'Ambrosio, Sanghamitra Mohanty, Carola Gianni, Jennifer Galvin, Giampaolo Vetta, Carlo Lavalle, Luigi Di Biase, Antonio Sorgente, Gian-Battista Chierchia, Carlo de Asmundis, Lukas Urbanek, Boris Schmidt, J Christoph Geller, Dhanunjaya R Lakkireddy, Moussa Mansour, Jacqueline Saw, Rodney P Horton, Douglas Gibson, Andrea Natale
BACKGROUND AND AIMS: Atrial fibrillation (AF) and chronic kidney disease (CKD) often coexist and share an increased risk of thromboembolism (TE). CKD concomitantly predisposes towards a pro-haemorrhagic state.Our aim was to evaluate the prognostic value of CKD in patients undergoing percutaneous left atrial appendage occlusion (LAAO). METHODS: 2124 consecutive AF patients undergoing LAAO were categorized into CKD stage 1+2 (n=1089), CKD stage 3 (n=796), CKD stage 4 (n=170), CKD stage 5 (n=69) based on the estimated glomerular filtration rate at baseline...
October 27, 2023: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://read.qxmd.com/read/37853268/the-use-of-microencapsulated-autologous-thrombi-for-modelling-chronic-thromboembolic-pulmonary-hypertension-in-rats
#35
JOURNAL ARTICLE
A A Karpov, A M Mihailova, D E Cherepanov, S G Chefu, L A Shilenko, D D Vaulina, M G Butskikh, Kh A Chervaev, E E Sidorova, D Yu Ivkin, M M Galagudza
Here we developed a model of chronic thromboembolic pulmonary hypertension (CTEPH) using repeated intravenous administration of microencapsulated thrombi with a controlled rate of biodegradation. Autologous thrombi encapsulated in alginate microspheres with a diameter of 190±48 μm were intravenously injected to rats 8 times every 4 days. In the comparison group, nonmodified thrombi were injected. After 6 weeks, a significant increase in systolic pressure in the right ventricle, a decrease in exercise tolerance, and an increase in the index of vascular wall hypertrophy were revealed in the group receiving injections of microencapsulated thrombi in comparison with the group receiving nonmodified thrombi and healthy animals...
October 19, 2023: Bulletin of Experimental Biology and Medicine
https://read.qxmd.com/read/37781686/hypercoagulable-state-in-patients-with-schizophrenia-different-effects-of-acute-and-chronic-antipsychotic-medications
#36
JOURNAL ARTICLE
Caiji Zheng, Haiyan Liu, Weifeng Tu, Lingyun Lin, Haiyun Xu
BACKGROUND: Previous studies reported higher incidences of venous thromboembolism and cardiovascular disease in schizophrenia patients and higher indicators of thrombosis, thrombocyte activation, and platelet dysfunction. OBJECTIVES: To check if first-episode schizophrenia (FES) patients have a hypercoagulable state and determine whether acute and chronic antipsychotics have the same effect on blood coagulation or fibrinolysis-related biomarkers. DESIGN: Case-control study...
2023: Therapeutic Advances in Psychopharmacology
https://read.qxmd.com/read/37767710/retrieval-of-chronically-implanted-dual-chamber-leadless-pacemakers-in-an-ovine-model
#37
JOURNAL ARTICLE
Rajesh S Banker, Marian K Rippy, Nicole Cooper, Petr Neužil, Derek V Exner, Devi G Nair, Daniel F Booth, David Ligon, Nima Badie, Mark Krans, Kenji Ando, Reinoud E Knops, James E Ip, Rahul N Doshi, Mayer Rashtian, Vivek Y Reddy
BACKGROUND: The clinical utilization of leadless pacemakers (LPs) as an alternative to traditional transvenous pacemakers is likely to increase with the advent of dual-chamber LP systems. Since device retrieval to allow LP upgrade or replacement will become an important capability, the first such dual-chamber, helix-fixation LP system (Aveir DR; Abbott, Abbott Park, IL) was specifically designed to allow catheter-based retrieval. In this study, the preclinical performance and safety of retrieving chronically implanted dual-chamber LPs was evaluated...
October 2023: Circulation. Arrhythmia and Electrophysiology
https://read.qxmd.com/read/37765060/recent-advances-in-the-treatment-of-pulmonary-arterial-hypertension-associated-with-connective-tissue-diseases
#38
REVIEW
Anna Smukowska-Gorynia, Weronika Gościniak, Patrycja Woźniak, Sylwia Iwańczyk, Karolina Jaxa-Kwiatkowska, Sylwia Sławek-Szmyt, Magdalena Janus, Jerzy Paluszkiewicz, Tatiana Mularek-Kubzdela
Pulmonary hypertension (PH) is a severe vascular complication of connective tissue diseases (CTD). Patients with CTD may develop PH belonging to diverse groups: (1) pulmonary arterial hypertension (PAH), (2) PH due to left heart disease, (3) secondary PH due to lung disease and/or hypoxia and (4) chronic thromboembolic pulmonary hypertension (CTEPH). PAH most often develops in systemic scleroderma (SSc), mostly in its limited variant. PAH-CTD is a progressive disease characterized by poor prognosis. Therefore, early diagnosis should be established...
September 5, 2023: Pharmaceuticals
https://read.qxmd.com/read/37760822/how-to-naturally-support-the-immune-system-in-inflammation-essential-oils-as-immune-boosters
#39
REVIEW
Magdalena Grazul, Paweł Kwiatkowski, Kacper Hartman, Anna Kilanowicz, Monika Sienkiewicz
Efficient functionality of the immune system is needed to fight against the development of infectious diseases, including, among others, serious recurrent chronic infections. Research has shown that many modern common diseases, such as inflammatory bowel diseases and cardiovascular diseases, e.g., thromboembolism, cancer, obesity, or depression, are connected with inflammatory processes. Therefore, new, good stimulators of the immune system's response are sought. They include synthetic compounds as well as biological preparations such as lipopolysaccharides, enzymes, bacterial metabolites, and secondary metabolites of plants, demonstrating a multidirectional effect...
August 25, 2023: Biomedicines
https://read.qxmd.com/read/37732541/multicenter-standardization-of-phase-resolved-functional-lung-mri-in-patients-with-suspected-chronic-thromboembolic-pulmonary-hypertension
#40
JOURNAL ARTICLE
Tawfik Moher Alsady, Andreas Voskrebenzev, Lea Behrendt, Karen Olsson, Claus Peter Heußel, Ekkehard Gruenig, Henning Gall, Ardeschir Ghofrani, Fritz Roller, Sebastian Harth, Helen Marshall, Paul J C Hughes, Jim Wild, Andrew J Swift, David G Kiely, Jürgen Behr, Julien Dinkel, Dietrich Beitzke, Irene M Lang, Kai Helge Schmidt, Karl Friedrich Kreitner, Thomas Frauenfelder, Silvia Ulrich, Okka W Hamer, Jens Vogel-Claussen
BACKGROUND: Detection of pulmonary perfusion defects is the recommended approach for diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). This is currently achieved in a clinical setting using scintigraphy. Phase-resolved functional lung (PREFUL) magnetic resonance imaging (MRI) is an alternative technique for evaluating regional ventilation and perfusion without the use of ionizing radiation or contrast media. PURPOSE: To assess the feasibility and image quality of PREFUL-MRI in a multicenter setting in suspected CTEPH...
September 21, 2023: Journal of Magnetic Resonance Imaging: JMRI
keyword
keyword
162945
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.